External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience ISPOR 2024
Roche and Genentech at

ISPOR 2024

May 05 - May 08
Atlanta, USA
ispor.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
May 6 / Roche and Genentech
Societal Costs of Alzheimer’s Disease: Informal Caregiver Burden and Patient Productivity Loss
A narrative literature review was performed to identify estimates of informal caregiver burden and market productivity loss and then a predictive algorithm was used to estimate nonmarket productiivty loss in AD.
Neuroscience Alzheimer Disease ISPOR-2024

Sign up or login to unlock the full suite of MEDICALLY features
May 6 / Roche and Genentech
Validating the Time-Use Algorithm to Estimate Productivity Loss in Persons With Multiple Sclerosis
A US employment survey of people with MS was used to estimate productivity loss as measured by EDSS, and market productivity loss estimates generated by an ICER algorithm was compared with empiric estimates from real-world data.
Neuroscience Multiple Sclerosis ISPOR-2024

Sign up or login to unlock the full suite of MEDICALLY features
May 6 / Roche and Genentech
Cough, dyspnea, chest pain or a composite? Analysis of key symptoms in metastatic non-small cell lung cancer (mNSCLC) clinical trials
Lung cancer remains the leading cause of cancer deaths worldwide. Given its highly symptomatic nature, clinical trials often focus on composite patient-reported endpoints of metastatic non-small cell lung symptoms including chest pain, cough, dyspnea, arm and shoulder pain, and general pain. This poster reports on analyzing the key symptoms in metastatic non-small cell lung cancer clinical trials.
Oncology Non-Small Cell Lung Cancer ISPOR-2024
02:30 PM
Duration 3hrs Atlanta, USA
Economic Benefit of Faricimab▼ Compared to Aflibercept 8mg in Treating Patients with Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the United States
El Moustaid F, Tabano D, Rosettie K, Ko S, Meer E, Brodie F
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3hrs Atlanta, USA
Higher Sars-Cov-2 Spike Antibody Levels Are Associated with Reduced Risk of Subsequent Symptomatic and Severe COVID-19: A Real-World Data Study
Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon
Infectious Disease | COVID-19

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3hrs Atlanta, USA
Validating the Time-Use Algorithm to Estimate Productivity Loss in Persons With Multiple Sclerosis
Julia Fox, Elizabeth S Mearns, Thomas Majda, Katherine L Rosettie, Nikki Win, Stacey Kowal
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3hrs Atlanta, USA
Societal Costs of Alzheimer’s Disease: Informal Caregiver Burden and Patient Productivity Loss
Julia Fox, Elizabeth S Mearns, Thomas Majda, Katherine L Rosettie, Nikki Win, Desilu Glazebrook, Stacey Kowal
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3hrs Atlanta, USA
Value assessment under uncertainty: Measuring insurance value and risk aversion for a novel neurological treatment using a stated preference survey
Jason Shafrin, Kyi-Sin Than, Jaehong Kim, Jacob Fajnor, Jakub, Tommy Majda, Liz Mearns, Stacey Kowal, Jakub Hlavka
Neuroscience | Neurodegenerative Diseases

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3hrs Atlanta, USA
Productivity Loss Among Persons With Multiple Sclerosis Treated With Ocrelizumab Versus Other Disease-Modifying Therapies
Caroline K Geiger, Katherine L Rosettie, Fadoua El Moustaid, Nicole G Bonine, R Brett McQueen
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3hrs Atlanta, USA
Expanding Cost-Effectiveness Analysis to Demonstrate Population-Level Treatment Impact on Patients and Society
Fadoua El Moustaid, Katherine L Rosettie
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3hrs Atlanta, USA
Cough, dyspnea, chest pain or a composite? Analysis of key symptoms in metastatic non-small cell lung cancer (mNSCLC) clinical trials
Amparo Yovanna Castro Sanchez,Patricia K. Corey-Lisle, Tracy Holt, Carla Mamolo
Oncology | Non-Small Cell Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:00 PM
Duration 15mins Podium
Health Equity Impacts of Alteplase for Ischemic Stroke in the United States: A Distributional Cost-Effectiveness Analysis
Stacey Kowal
Neuroscience | Acute Ischemic Stroke

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:30 PM
Duration 2hrs Atlanta, USA
The Impact of Funding Tocilizumab for the Inpatient Treatment of COVID-19 in the United States: A Distributional Cost-Effectiveness Analysis
Rosettie K, Best J, Kowal S
Infectious Disease | COVID-19

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3hrs Atlanta, USA
Machine Learning vs Traditional Statistics: Developing a Novel Proxy for HPV-associated LA SCCHN
Olivia Shane, Robert Schuldt, Achal Patel, David Fox, Dustin Schrader, Rashed Harun
Oncology | Squamous Cell Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:30 PM
Duration 3hrs Atlanta, USA
Health Care Resource Utilization and Costs Among Patients With Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A U.S. Claims Analysis
Chia-Wei Lin, Rongrong Wang, Eunice Tzeng
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.